NDC 70518-0970-2 - Aripiprazole

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70518-0970
Requested NDC
70518-0970-2
Package NDCs from labels
70518-0970-0, 70518-0970-2, 70518-0970-1, 70518-0970-3
Manufacturer
REMEDYREPACK INC.
Effective date
2026-07-02
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Aripiprazole - REMEDYREPACK INC.REMEDYREPACK INC.2026-07-02HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-0970-0Aripiprazole30 in 1 BLISTER PACKTABLET3015
70518-0970-1Aripiprazole30 in 1 BOXTABLET3015
70518-0970-2Aripiprazole1 in 1 POUCHTABLET115
70518-0970-3Aripiprazole180 in 1 BOTTLE, PLASTICTABLET18015

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-0970ARIPIPRAZOLE TABLET [REMEDYREPACK INC.]13Current NDC, Legacy NDC, 4 package rows20250504_a1191a90-eb83-4a59-948c-b9774d2c83a5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 7 · 121 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ARIPIPRAZOLEARIPIPRAZOLECamber Pharmaceuticals, Inc.3718e585-06b9-40fd-a3eb-18b6497a42352017-08-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 349547
rxcui: 349553
rxcui: 602964
rxcui: 349545
rxcui: 349490
rxcui: 402131
unii: 82VFR53I78

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.